Logo

RenalytixAI

In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More

News items for the week of Nov. 28, 2022.

360Dx Top 30 Rises 2 Percent After Months of Decline

Of the 30 companies in the index, 22 saw their stock prices rise, while eight firms saw their share prices decrease.

Renalytix Posts $2.9M in Revenue for Fiscal 2022

The kidney disease-focused in vitro diagnostics firm nearly doubled the previous year's revenue and posted a net loss of $45.3 million in the year ending June 30.

360Dx Top 30 Drops 5 Percent in June

Of the 30 diagnostic companies in the index, nine saw their share prices increase, while 21 saw stock prices decline.

In Brief This Week: Qiagen, Renalytix, OpGen, PerkinElmer, Avacta, Paige, More

News items for the in vitro diagnostics industry for the week of April 4, 2022.